Changda Liu

Changda Liu

Auto-generated profile, based on publicly available information

Changda Liu

Tongji University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2024 in International Journal of Digital Earth
Verified
Journal Article
Open access
BLBinbin Li
Binbin Li
HXHuan Xie
Huan Xie
SLShijie Liu
Shijie Liu
YXYuanting Xi
Yuanting Xi
CLChangda Liu
Changda Liu
XTXiaohua Tong
Xiaohua Tong

19 January 2017 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
CLChangda Liu
Changda Liu
NYNan Yang
Nan Yang
XCXiaoke Chen
Xiaoke Chen
JTJody Tversky
Jody Tversky
Jixun ZhanJixun Zhan
Jixun Zhan
XLXiumin Li
Xiumin Li

4 October 2025 in ISPRS Journal of Photogrammetry and Remote Sensing
Verified
Journal Article
Closed access
CLChangda Liu
Changda Liu
HXHuan Xie
Huan Xie
KLKuifeng Luan
Kuifeng Luan
QXQi Xu
Qi Xu
YSYuan Sun
Yuan Sun
XTXiaohua Tong
Xiaohua Tong

1 December 2021 in Journal of Asthma and Allergy
Verified
Journal Article
Open access
PDF file
YSYing Song
Ying Song
ZWZhen-Zhen Wang
Zhen-Zhen Wang
LWLixin Wang
Lixin Wang
PFPaul Faybusovich
Paul Faybusovich
KSKamal Srivastava
Kamal Srivastava
XLXiumin Li
Xiumin Li
Background: It has been demonstrated that ASHMI (antiasthma-simplified herbal medicine intervention) can improve airway function and reduce inflammation in human asthmatic patients with high safety and tolerability. In addition, ASHMI significantly suppresses Th2 cytokine production and increases Th1 cytokine production in treating asthma. Objective: Allergic asthma is associated with dysregulation of cytokines. We focused on IL-5 and IL-10 as signature Th2 and Treg cytokines to characterize ASHMI immunomodulatory components. Methods: The effects of ASHMI and individual herbal constituents on IL-5 and IL-10 production by PBMCs from asthmatic subjects were determined ex vivo. Sophora flavescens (SF)-F2, containing alkaloid compounds, effects on PBMC IL-10 and IL-5 production in the presence or absence of dexamethasone (Dex), and on DNA methylation levels at the foxp3 gene promoter were determined. Results: The ratio of anti-CD3/CD28 stimulated IL-10/IL-5 production by PBMCs from asthmatic subjects was significantly reduced compared to healthy subjects. In PBMCs from asthmatic subjects, ASHMI significantly reduced IL-5 production and increased IL-10 secretion in a dose-dependent manner (p < 0.05– 0.01). SF-F2 was most effective in increasing IL-10, whereas SF-F4 (flavonoid compounds) was most effective in suppressing IL-5 production. Dex-treated PBMCs from asthma subjects showed a trend of increasing ratio of IL-10/IL-5 while demonstrating reduced levels in both IL-5 and IL-10 (p < 0.05). Co-culture with Dex and SF-F2 significantly prevented Dex suppression of IL-10, while retained Dex-suppression of IL-5 production, and increased IL-10/IL-5 ratio by Dex. Co-culture with SF-F2 and Dex significantly reduced DNA methylation levels at the foxp3 gene promoter at CpG− 126. Conclusion: The SF alkaloid-rich fraction may be responsible for ASHMI induction of IL-10 production by PBMCs and plays a synergistic effect with Dex for augmenting IL-10/IL-5 ratio.

12 December 2024 in International Journal of Applied Earth Observation and Geoinformation
Verified
Journal Article
Open access
CLChangda Liu
Changda Liu
HXHuan Xie
Huan Xie
QXQi Xu
Qi Xu
JLJie Li
Jie Li
YSYuan Sun
Yuan Sun
XTXiaohua Tong
Xiaohua Tong